` QNTM (Quantum BioPharma Ltd) vs S&P TSX Composite Index (Canada) Comparison - Alpha Spread

Q
QNTM
vs
S
S&P TSX Composite Index (Canada)

Over the past 12 months, QNTM has significantly outperformed S&P TSX Composite Index (Canada), delivering a return of +131% compared to the S&P TSX Composite Index (Canada)'s +23% growth.

Stocks Performance
QNTM vs S&P TSX Composite Index (Canada)

Loading
QNTM
S&P TSX Composite Index (Canada)
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
QNTM vs S&P TSX Composite Index (Canada)

Loading
QNTM
S&P TSX Composite Index (Canada)
Difference
www.alphaspread.com

Performance By Year
QNTM vs S&P TSX Composite Index (Canada)

Loading
QNTM
S&P TSX Composite Index (Canada)
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Quantum BioPharma Ltd vs Peers

S&P TSX Composite Index (Canada)
QNTM
LLY
JNJ
ROG
AZN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Quantum BioPharma Ltd
Glance View

Market Cap
48.6m CAD
Industry
Pharmaceuticals

Quantum BioPharma Ltd is a CA-based company operating in Pharmaceuticals industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-05-29. Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The firm is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

QNTM Intrinsic Value
Not Available
Q
Back to Top